Stock

Apimeds Pharmaceuticals US, Inc. APUS

$6.89+11.04%

All stocks Create account to unlock

Overview

APUS market data

Price History

APUS price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for APUS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

2 captured

8-K filing — Apimeds Pharmaceuticals US, Inc. (APUS) · Jul 13, 2026, 8:30 PM

Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY · May 26, 2026, 9:32 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock